EP
CLB icon

Edgestream Partners’s Core Laboratories CLB Stock Holding History

Edgestream Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-21,516
Closed -$838K – 501
2021
Q2 		$838K Sell
21,516
-211,088
-91% -$7.57M 0.05% 312
2021
Q1 		$6.7M Buy
232,604
+123,788
+114% +$4.23M 0.37% 94
2020
Q4 		$2.88M Buy
+108,816
New +$2.22M 0.15% 183
2020
Q3 		– Sell
-24,520
Closed -$498K – 295
2020
Q2 		$498K Sell
24,520
-37,062
-60% -$664K 0.03% 272
2020
Q1 		$637K Buy
+61,582
New +$1.72M 0.06% 227
2019
Q2 		– Sell
-10,711
Closed -$738K – 236
2019
Q1 		$738K Sell
10,711
-18,963
-64% -$1.27M 0.11% 149
2018
Q4 		$1.77M Buy
+29,674
New +$2.56M 0.31% 103

Other funds holding CLB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Edgestream Partners's CLB Position: Q3 2021 in Review

Edgestream Partners sold out of Core Laboratories (CLB) in Q3 2021, closing a stake of 21,516 shares — an estimated $838K sold.

Edgestream Partners first reported a position in CLB in Q4 2018 and held it in 7 quarters. The position peaked at $6.7M in Q1 2021. 198 funds tracked by Wall St. Rank hold CLB as of Q3 2021.

  • Edgestream Partners reported no remaining Core Laboratories position as of Q3 2021 after selling out during the quarter.
  • Edgestream Partners sold 21,516 Core Laboratories shares in Q3 2021, an estimated $838K.
  • Edgestream Partners first reported a position in Core Laboratories in Q4 2018 and held it in 7 quarters.
  • Edgestream Partners's Core Laboratories position peaked at $6.7M in Q1 2021.
  • 198 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2021.

Based on Edgestream Partners's 13F filing for Q3 2021, filed 15 Nov 2021.